Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Microsoft Corporation (MSFT): Windows RT Desperation Is Starting to Surface

Page 1 of 2

Here’s some marketing 101: If people don’t want your product, then give them an incentive to want it. That’s exactly the thinking Microsoft Corporation (NASDAQ:MSFT) has had over the past few weeks with its tablet marketing.

Last week the company started throwing in a free keyboard — which usually costs $100 — with the purchase of a Surface RT. ­This week the company has apparently lowered its OEM software-licensing fee for smaller Windows RT tablets, according to an article from Bloomberg. The two changes come as Windows RT struggles to gain the attention of tablet consumers.

Microsoft Corporation (MSFT)

Is it really that bad?
So are things really that bad for Microsoft Corporation (NASDAQ:MSFT), or are these just typical promotional incentives that all companies do to move products?

It’s not the latter. Things really are that bad.

IDC says Windows RT has 0.4% of tablet platform market share right now. Yes, Windows RT has only been out since October of last year, but projections for future RT market share are only expected to hit 2.7% by 2017. On top of this, tablet makers have been cooling toward Windows RT as of late.

Though HTC is about to release a 7-inch tablet with the RT platform, the company recently dropped its plans to produce a 12-inch RT tablet. Acer and ASUS are basically staying away from the platform, with Acer CEO JT Wang calling the software “very immature.” Samsung also dropped plans to release Windows RT tablets in the U.S. and Germany because demand hasn’t been strong enough.

Untapped potential
For better or worse, Dell Inc. (NASDAQ:DELL) is committed to both Windows RT and 8. But a few weeks ago Dell cut is XPS 10 tablet hybrid from $500 to $300 — likely due to slow sales. Despite this, the company seems confident Windows is the way to go on tablets, and is developing a successor to the XPS 10 that will likely run RT. But Dell doesn’t even make it on the top-five list of tablet sellers, and Microsoft Corporation (NASDAQ:MSFT) itself is at the bottom of the list.

Microsoft investors should be worried about this. The company that used to have such dominance in the software platform business can’t get OEMs to sell significant numbers of its new tablet OS ­– something the company never had to worry about with its PC software. Apple Inc. (NASDAQ:AAPL), Samsung, ASUS and, Inc. (NASDAQ:AMZN) all come before Microsoft Corporation (NASDAQ:MSFT) when it comes to tablet sales.

Apple takes the No. 1 spot in all tablet shipments for Q1 2013, and commands 39.6% market share among tablet vendors. The company shipped 19.5 million tablet units in the quarter, compared to Microsoft Corporation (NASDAQ:MSFT)’s 0.9 million. But even though Apple Inc. (NASDAQ:AAPL) is the No. 1 vendor, its iOS takes the second spot behind Android. Apple’s second-place spot should be an indicator as to how difficult it is to gain additional market share even when selling millions of tablets ­– which means Microsoft has an extremely long road ahead of it.

Microsoft Corporation (NASDAQ:MSFT) still has a few companies on its side, though. A QUALCOMM, Inc. (NASDAQ:QCOM) executive said last month that the company is “very optimistic” about Windows RT. Obviously, the chip maker has some stake in the success of RT ­ — it makes ARM Holdings plc (ADR) (NASDAQ:ARMH)-based Snapdragon processors in Dell Inc. (NASDAQ:DELL) tablets running RT. Qualcomm has also said that it’s working with more OEMs that will release new RT devices in the near future.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!